Doctor profile · Federal record
Dr. Bankim Bhatt, MD
Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · Center Valley, PA
- NPI 1366554578
- Accepts Medicare
- MIPS 90.3 / 100 · 2023
- 28 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
5445 Lanark RD Ste 300
Center Valley, PA 180348694
(484) 526-7300
fax (866) 449-5832
Credentials & registration
- NPI registered
- September 2006 — 20 yrs on file
- Profile last updated
- January 13, 2020
- Year of graduation
- 1998 — 28 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State license (1)
- Pennsylvania #MD418905
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1366554578. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
4,383
Distinct HCPCS
10
Medicare allowed
$163,370
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 3,120 | 37 | $23 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 339 | 262 | $124 | |
G0109 |
Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes | 266 | 25 | $16 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 129 | 87 | $34 | |
96372 |
Injection of drug or substance under skin or into muscle | 85 | 46 | $14 | |
G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes | 81 | 49 | $55 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 72 | 34 | $77 | |
83036 |
Hemoglobin a1c level | 65 | 59 | $10 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 58 | 58 | $162 | |
99222 |
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 56 | 55 | $126 |
In context: peer comparison
Among 4 peers in this city , average services per provider: 266. This provider delivers 16× the peer median.Open Payments
Industry payments received
All-time total
$779
Transactions
13
Manufacturers
7
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novo Nordisk Inc | 7 | $259.78 | |
| Lilly USA, LLC | 1 | $124.74 | |
| Kyowa Kirin, Inc. | 1 | $115.73 | |
| Alexion Pharmaceuticals, Inc. | 1 | $96.00 | |
| Abbott Laboratories | 1 | $89.22 | |
| Dexcom, Inc. | 1 | $47.88 | |
| BETA BIONICS, INC. | 1 | $45.55 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
710
Patients
238
Total drug cost
$480,208
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Levothyroxine Sodium | Generic | 140 | 48 | $2,286 |
| Ozempic (Semaglutide) | Brand | 106 | 39 | $175,112 |
| Jardiance (Empagliflozin) | Brand | 85 | 30 | $81,508 |
| Metformin Hcl | Generic | 51 | 22 | $511 |
| Trulicity (Dulaglutide) | Brand | 48 | 12 | $70,039 |
| Metformin Hcl Er (Metformin Hcl) | Brand | 46 | 17 | $1,052 |
| Novolog Flexpen (Insulin Aspart) | Brand | 36 | 19 | $47,446 |
| Nano 2nd Gen Pen Needle (Pen Needle, Diabetic) | Brand | 35 | 19 | $4,983 |
| Tresiba Flextouch U-100 (Insulin Degludec) | Brand | 28 | 15 | $22,735 |
| Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) | Brand | 27 | 17 | $19,635 |
Hospital affiliations
Frequently asked questions
What is Dr. Bankim Bhatt's medical specialty?
Dr. Bankim Bhatt practices Endocrinology, Diabetes & Metabolism Physician in Center Valley, PA.
Where does Dr. Bankim Bhatt practice?
Dr. Bankim Bhatt practices at 5445 Lanark RD Ste 300, Center Valley, PA 180348694. Office phone: 4845267300.
What is Dr. Bankim Bhatt's NPI?
Dr. Bankim Bhatt's National Provider Identifier (NPI) is 1366554578, issued by NPPES.
Does Dr. Bankim Bhatt accept Medicare assignment?
Yes. Dr. Bankim Bhatt accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Bankim Bhatt commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Established patient office or other outpatient visit (HCPCS 99214); Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes (HCPCS G0109). Source: CMS Medicare Physician & Other Practitioners file.